120 related articles for article (PubMed ID: 3886534)
1. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
2. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
Ayeni AO; Thomson DM; MacFarlane JK; Daly D
Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of leucocyte adherence inhibition microassay using colorectal cancer cell lines.
Machida S; Yamauchi M; Sato M; Ishioka T; Takashima K; Nishikawa T; Fukushima M; Koie H
Gan; 1980 Jun; 71(3):387-92. PubMed ID: 6998824
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels.
Shani A; Ritts RE; Thynne GS; Weiland LH; Silvers A; Moertel CG; Go VL
Int J Cancer; 1978 Aug; 22(2):113-9. PubMed ID: 359486
[TBL] [Abstract][Full Text] [Related]
8. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancers.
Berner Y; Fink A; Shani A; Weisman Z; Eliraz A; Bruderman I; Bentwich Z
Oncology; 1986; 43(5):327-34. PubMed ID: 3531955
[TBL] [Abstract][Full Text] [Related]
10. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
11. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
12. Automated leucocyte adherence inhibition testing in patients with colorectal cancer.
McLeod DK; Isbister WH
Immunol Cell Biol; 1987 Oct; 65 Pt 5():377-85. PubMed ID: 3325409
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.
Tank B; Marquet RL; Vennemans E; Westbroek DL
J Cancer Res Clin Oncol; 1986; 112(3):276-80. PubMed ID: 3782265
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
Cavallini G; Berti G; Tioli P
Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant.
Labateya N; Thomson DM; Reid EC
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adherence inhibition assay in the diagnosis and follow-up of colorectal cancer patients.
Weisman Z; Shani A; Fink A; Shindel A; Sela A; Wechsler U; Pfeffermann R; Bentwich Z
Oncology; 1986; 43(1):23-6. PubMed ID: 3941799
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
19. A computerized tube leukocyte adherence inhibition assay in the diagnosis of human lung cancer.
Fink A; Eliraz A; Bruderman I; Wishnitzer R; Shindler D; Shani A; Offer S; Harpaz N; Bentwich Z
Diagn Immunol; 1985; 3(4):171-6. PubMed ID: 2417775
[TBL] [Abstract][Full Text] [Related]
20. Modulation of antigen-induced leukocyte adherence inhibition by metabolites of arachidonic acid and intracellular nucleotides.
Thomson DM; Phelan K; Scanzano R; Fink A
Int J Cancer; 1982 Sep; 30(3):311-9. PubMed ID: 6752047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
